PROCEPT BIOROBOTICS CORP (PRCT)
US74276L1052 - Common Stock
PROCEPT BIOROBOTICS CORP
NASDAQ:PRCT (9/16/2024, 8:00:00 PM)
After market: 81.99 0 (0%)81.99
+0.88 (+1.08%)
Company Profile
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. The company is headquartered in San Jose, California and currently employs 626 full-time employees. The company went IPO on 2021-09-15. The firm develops, manufactures and sells the AquaBeam Robotic System, which is an image-guided surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). The AquaBeam Robotic System employs a single-use disposable handpiece to deliver the Company’s proprietary Aquablation therapy, which combines real-time, multi-dimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The firm designed Aquablation therapy to deliver effective, safe and durable outcomes for males suffering from lower urinary tract symptoms, (LUTS), due to BPH that are independent of prostate size and shape or surgeon experience.
Company Info
PROCEPT BIOROBOTICS CORP
150 Baytech Drive
San Jose CALIFORNIA
P: 16502329832
CEO: Reza Zadno
Employees: 626
Website: https://www.procept-biorobotics.com/
PRCT News
19 days ago - PROCEPT BioRoboticsPROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 202419 days ago - PROCEPT BioRoboticsPROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024SAN JOSE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing...
a month ago - Market News VideoNoteworthy Wednesday Option Activity: SSTK, AMBA, PRCTa month ago - PROCEPT BioRoboticsPROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® TherapyDesigned to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better clinical outcomes
a month ago - PROCEPT BioRoboticsPROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® TherapyDesigned to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better clinical...
a month ago - InvestorPlace3 Robotics Stocks to Sell in August Before They Crash & BurnDiscover which robotics stocks to sell in August and why, ensuring you avoid potential market downturns and secure your investments.
PRCT Twits
Here you can normally see the latest stock twits on PRCT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
